Thymosin Alpha-1 10mg

Research applications

• T-cell maturation and differentiation research
• Cytokine signalling studies in immune cell models
• Innate immune cell activity research (dendritic cells, NK cells)
• Animal models of immune challenge and response

What the literature reports on Thymosin Alpha-1

Thymosin Alpha-1 was originally identified as a component of thymosin fraction 5, an extract of thymic tissue studied for its role in T-cell development. Its 28-residue, N-acetylated sequence has been characterised extensively, and it remains a reference compound in the study of thymic peptide hormones.

T-cell research

In vitro studies have reported that Thymosin Alpha-1 influences T-cell maturation markers and modulates cytokine production in cultured lymphocytes, with research describing effects on both helper and cytotoxic T-cell populations. This research has been extended to studies of thymic function in animal models, examining how exogenous Thymosin Alpha-1 interacts with endogenous thymic peptide signalling.

Innate immune signalling research

Beyond T-cell effects, research has examined Thymosin Alpha-1's activity on innate immune cell populations, including dendritic cells and natural killer cells, with studies reporting changes in activation markers and cytokine secretion profiles following exposure in cell culture models.

Immune challenge models

Animal studies have used models of immune challenge, including infection and vaccination-response paradigms, to study how Thymosin Alpha-1 administration modulates the resulting immune response, with reported effects on markers of immune cell activation and cytokine profiles across several independent research programmes.

Comparative recovery-peptide research

Within this catalogue's RECOVER category, Thymosin Alpha-1 is studied for its immune-signalling profile as distinct from the tissue-repair mechanisms examined for BPC-157 and TB-500, and researchers designing recovery-focused protocols sometimes study these compounds in parallel to separate immune-modulatory from structural tissue-repair endpoints.

Toll-like receptor signalling research

Mechanistic research has examined Thymosin Alpha-1's interaction with toll-like receptor signalling pathways in immune cells, reporting modulation of downstream transcription factor activity implicated in innate immune cell activation, a research thread that has informed proposed mechanistic models for its broader immunomodulatory profile.

Laboratory handling

Thymosin Alpha-1 should be stored as lyophilised powder at -20°C, protected from light and moisture, until reconstitution. Reconstitution follows standard peptide practice: diluent introduced slowly along the vial wall, followed by gentle mixing.

• Lyophilised powder: store at -20°C, protected from light, until reconstitution.
• Reconstitution: introduce diluent slowly along the vial wall; mix gently, do not shake.
• Post-reconstitution: 2-8°C for short-term laboratory use; avoid repeated freeze-thaw cycles.
• Each batch ships with a certificate of analysis confirming ≥99% purity by HPLC and identity by mass spectrometry.

See the peptide reconstitution and storage guide for a full protocol reference. This product is intended for laboratory research use only.